The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Anders Lehmann

AstraZeneca R&D

Mölndal

Sweden

[email]@astrazeneca.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • AstraZeneca R&D, Mölndal, Sweden. 2008 - 2009
  • Gastrointestinal Pharmacology, Astra Zeneca R&D Mölndal, Mölndal, Sweden. 1999 - 2005

References

  1. GABAB receptors as drug targets to treat gastroesophageal reflux disease. Lehmann, A. Pharmacol. Ther. (2009) [Pubmed]
  2. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action. Lehmann, A., Antonsson, M., Holmberg, A.A., Blackshaw, L.A., Brändén, L., Bräuner-Osborne, H., Christiansen, B., Dent, J., Elebring, T., Jacobson, B.M., Jensen, J., Mattsson, J.P., Nilsson, K., Oja, S.S., Page, A.J., Saransaari, P., von Unge, S. J. Pharmacol. Exp. Ther. (2009) [Pubmed]
  3. Novel treatments of GERD: focus on the lower esophageal sphincter. Lehmann, A. Eur. Rev. Med. Pharmacol. Sci (2008) [Pubmed]
  4. Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice. Lehmann, A., Holmberg, A.A., Bhatt, U., Bremner-Danielsen, M., Brändén, L., Elg, S., Elebring, T., Fitzpatrick, K., Geiss, W.B., Guzzo, P., Jensen, J., Jerndal, G., Mattsson, J.P., Nilsson, K., Olsson, B.M. Br. J. Pharmacol. (2005) [Pubmed]
  5. Z-338. Zeria/Yamanouchi. Lehmann, A. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  6. Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain. Lehmann, A., Mattsson, J.P., Edlund, A., Johansson, T., Ekstrand, A.J. Neurochem. Res. (2003) [Pubmed]
  7. Inhibitory effects of GABA(B) receptor agonists on swallowing in the dog. Lehmann, A., Bremner-Danielsen, M., Brändén, L., Kärrberg, L. Eur. J. Pharmacol. (2002) [Pubmed]
  8. Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs. Lehmann, A., Blackshaw, L.A., Brändén, L., Carlsson, A., Jensen, J., Nygren, E., Smid, S.D. Gastroenterology (2002) [Pubmed]
  9. Effects of antagonism of NMDA receptors on transient lower esophageal sphincter relaxations in the dog. Lehmann, A., Brändén, L. Eur. J. Pharmacol. (2001) [Pubmed]
  10. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog. Lehmann, A., Hansson-Brändén, L., Kärrberg, L. Eur. J. Pharmacol. (2000) [Pubmed]
  11. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs. Lehmann, A., Antonsson, M., Bremner-Danielsen, M., Flärdh, M., Hansson-Brändén, L., Kärrberg, L. Gastroenterology (1999) [Pubmed]
 
WikiGenes - Universities